These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 15009714)

  • 1. Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.
    Tsao H; Goel V; Wu H; Yang G; Haluska FG
    J Invest Dermatol; 2004 Feb; 122(2):337-41. PubMed ID: 15009714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines.
    Tsao H; Zhang X; Fowlkes K; Haluska FG
    Cancer Res; 2000 Apr; 60(7):1800-4. PubMed ID: 10766161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas.
    Reifenberger J; Knobbe CB; Sterzinger AA; Blaschke B; Schulte KW; Ruzicka T; Reifenberger G
    Int J Cancer; 2004 Apr; 109(3):377-84. PubMed ID: 14961576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRAF alterations are associated with complex mutational profiles in malignant melanoma.
    Daniotti M; Oggionni M; Ranzani T; Vallacchi V; Campi V; Di Stasi D; Torre GD; Perrone F; Luoni C; Suardi S; Frattini M; Pilotti S; Anichini A; Tragni G; Parmiani G; Pierotti MA; Rodolfo M
    Oncogene; 2004 Aug; 23(35):5968-77. PubMed ID: 15195137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma.
    Goel VK; Lazar AJ; Warneke CL; Redston MS; Haluska FG
    J Invest Dermatol; 2006 Jan; 126(1):154-60. PubMed ID: 16417231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines.
    Tsao H; Zhang X; Benoit E; Haluska FG
    Oncogene; 1998 Jul; 16(26):3397-402. PubMed ID: 9692547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma.
    Guldberg P; thor Straten P; Birck A; Ahrenkiel V; Kirkin AF; Zeuthen J
    Cancer Res; 1997 Sep; 57(17):3660-3. PubMed ID: 9288767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High BRAF mutation frequency does not characterize all melanocytic tumor types.
    Saldanha G; Purnell D; Fletcher A; Potter L; Gillies A; Pringle JH
    Int J Cancer; 2004 Sep; 111(5):705-10. PubMed ID: 15252839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN/MMAC1 expression in melanoma resection specimens.
    Deichmann M; Thome M; Benner A; Egner U; Hartschuh W; Näher H
    Br J Cancer; 2002 Dec; 87(12):1431-6. PubMed ID: 12454773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KIT, NRAS, BRAF and PTEN mutations in a sample of Swedish patients with acral lentiginous melanoma.
    Zebary A; Omholt K; Vassilaki I; Höiom V; Lindén D; Viberg L; Kanter-Lewensohn L; Johansson CH; Hansson J
    J Dermatol Sci; 2013 Dec; 72(3):284-9. PubMed ID: 23993026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRAF and NRAS mutations are frequent in nodular melanoma but are not associated with tumor cell proliferation or patient survival.
    Akslen LA; Angelini S; Straume O; Bachmann IM; Molven A; Hemminki K; Kumar R
    J Invest Dermatol; 2005 Aug; 125(2):312-7. PubMed ID: 16098042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing.
    Edlundh-Rose E; Egyházi S; Omholt K; Månsson-Brahme E; Platz A; Hansson J; Lundeberg J
    Melanoma Res; 2006 Dec; 16(6):471-8. PubMed ID: 17119447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploration of genetic alterations in human endometrial cancer and melanoma: distinct tumorigenic pathways that share a frequent abnormal PI3K/AKT cascade.
    Ogawa K; Sun C; Horii A
    Oncol Rep; 2005 Dec; 14(6):1481-5. PubMed ID: 16273242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.
    Omholt K; Platz A; Kanter L; Ringborg U; Hansson J
    Clin Cancer Res; 2003 Dec; 9(17):6483-8. PubMed ID: 14695152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAF proteins exert both specific and compensatory functions during tumour progression of NRAS-driven melanoma.
    Dorard C; Estrada C; Barbotin C; Larcher M; Garancher A; Leloup J; Beermann F; Baccarini M; Pouponnot C; Larue L; Eychène A; Druillennec S
    Nat Commun; 2017 May; 8():15262. PubMed ID: 28497782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRAF mutations are common somatic events in melanocytic nevi.
    Kumar R; Angelini S; Snellman E; Hemminki K
    J Invest Dermatol; 2004 Feb; 122(2):342-8. PubMed ID: 15009715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation analysis of the EGFR-NRAS-BRAF pathway in melanomas from black Africans and other subgroups of cutaneous melanoma.
    Akslen LA; Puntervoll H; Bachmann IM; Straume O; Vuhahula E; Kumar R; Molven A
    Melanoma Res; 2008 Feb; 18(1):29-35. PubMed ID: 18227705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation and allelic loss of the PTEN/MMAC1 gene in primary and metastatic melanoma biopsies.
    Birck A; Ahrenkiel V; Zeuthen J; Hou-Jensen K; Guldberg P
    J Invest Dermatol; 2000 Feb; 114(2):277-80. PubMed ID: 10651986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTEN/MMAC1 in malignant melanoma and its importance for tumor progression.
    Poetsch M; Dittberner T; Woenckhaus C
    Cancer Genet Cytogenet; 2001 Feb; 125(1):21-6. PubMed ID: 11297763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRAF and NRAS mutations in melanoma and melanocytic nevi.
    Poynter JN; Elder JT; Fullen DR; Nair RP; Soengas MS; Johnson TM; Redman B; Thomas NE; Gruber SB
    Melanoma Res; 2006 Aug; 16(4):267-73. PubMed ID: 16845322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.